RxDoctor Payments Data

David Pereira, MD

Orthopaedic Surgery · New York, NYNPI 1942300207

Payments from drug & device makers

$2,020in general payments, 2019–2025

Across 28 payments — averaging $72.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Suvon Surgical LLC$628
  • Johnson & Johnson$599
  • Arthrex$462
  • Miach Orthopaedics, Inc.$161
  • Fidia Pharma USA Inc.$49
  • Dynasplint Systems Inc.$48
  • plus $72 from 3 others

What the payments were for

  • Travel & lodging$83441%
  • Food & beverage$1,18659%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Suvon Surgical LLC3$628
Johnson & Johnson12$599
Arthrex2$462
Miach Orthopaedics, Inc.1$161
Fidia Pharma USA Inc.5$49
Dynasplint Systems Inc.1$48
Ferring Pharmaceuticals Inc.2$34
Medical Device Business Services, Inc.1$22
Amgen1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,020 in reported general payments places this provider in the 35th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York

Medicare billing

Part B allowed, 2024
$169,901
Medicare patients
273
Services billed
1,070

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Naproxen70$542
Celecoxib18$256
Meloxicam98$250
Diclofenac Sodium11$227
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen12$61

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →